SMARCB1-deficient sinonasal carcinomas account for 4.7% of carcinomas of the sinonasal tract in this single-institution cohort, while no cases of SMARCA4-deficient sinonasal carcinoma were identified. The gene discussed is SMARCA4; the disease is nasal cavity and paranasal sinus carcinoma.